Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

A patient with lupus experienced a condition where their immune cells became overactive.

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.